Page 3 - ஒன்றுபட்டது மாநிலங்களில் தேசிய நிறுவனங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients The Montreal Heart Institute (MHI) announces that the COLCORONA study results are published today in The Lancet Respiratory Medicine. The article, which is entitled Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomized, double-blinded, adaptive, placebo-controlled, multicentre trial, concludes that, given the lack of oral therapies available to prevent COVID-19 complications among non-hospitalized patients and the observed benefit of colchicine in patients with a PCR-confirmed diagnosis of COVID-19, this anti-inflammatory drug could be considered as a treatment for those at risk of complications. Given the current pandemic, while awaiting collective immunity through vaccination around the world, the need for treatments to prevent COVID-19 complications among patients who contract the disease remains. Our study showed that colchicine could be used to redu

South africaUnited statesJean claude tardifYves rosenbergEmily hendersonMontreal heart instituteArtery disease branchUnited states national institutes of healthResearch centreNational heartBlood instituteLancet respiratoryPrincipal investigatorFamilial mediterranean feverCoronary artery disease branchUnited states national institutes